GSK hit with EU Court ruling over ‘pay-for-delay’ drug case
admin 31st January 2020 Uncategorised 0The ruling harks back to the CMA’s 2016 case that found GlaxoSmithKline had agreed to make payments totalling over £50 million to other generic suppliers of paroxetine.
More: GSK hit with EU Court ruling over ‘pay-for-delay’ drug case
Source: News